“Design and Implementation of the Site Activation Guidance (SAG) in the National Drug Abuse Treatment Clinical Trials Network (NDAT CTN)”, in SOCRA 30th Annual Conference: Disseminating Knowledge to Enhance Clinical Research Innovation, Virtual, 2021.
, “Design of the Buprenorphine Physician-Pharmacist Collaborative Care of Patients with Opioid Use Disorder. ”, in 81st Annual Scientific Meeting of the College of Problems on Drug Disorders (CPDD), , San Antonio, TX. , 2019.
, “Developing Materials for Transplant Centers to Share BMT CTN Clinical Trial Results with their Patients: A Pilot Study (Poster).”, in NCI ASCO Cancer Trials Accrual Symposium, Bethesda, MD, 2010.
, “Development and Validation of a Novel Genomic Classifier for Predicting Metastatic Prostate Cancer in Patients Undergoing Radical Prostatectomy”, in Society of Urologic Oncology, Bethesda, MD, 2012.
“The Development of a Clinical Decision Support for Illicit Substance Use in Primary Care”, in 8th Annual International Network on Brief Interventions for Alcohol Problems (INEBRIA), Boston, MA, 2011.
, “The Development of AMD in Participants with No or Small Drusen in the Age-Related Eye Disease Study (AREDS)”, in Association for Research in Vision and Ophthalmology - ARVO, Ft. Lauderdale, FL, 2012.
, “Development of an Accrual Assessment Tool for BMT CTN Transplant Trials: A Proactive Approach”, in NCI ASCO Cancer Trials Accrual Symposium Poster Session, Bethesda, MD, 2010.
, “Dietary Glycemic Index is Related to Progression of Age-Related Macular Degeneration”, in Annual Meeting, Association for Research in Vision and Ophthalmology (ARVO), Fort Lauderdale, FL, 2007.
, “Dietary Lipids Intake and Incident Advanced Age-Related Macular Degeneration (AMD) in the Age-Related Eye Disease Study (AREDS)”, in Annual Meeting, Association for Research in Vision and Ophthalmology (ARVO), Fort Lauderdale, FL, 2005.
, “Dietary Zinc and Risk for Age-Related Macular Degeneration”, in Annual Meeting, Association for Research in Vision and Ophthalmology (ARVO), Fort Lauderdale, FL, 2005.
, “Differential Impact of HLA-A, -B, and -DRB1 Mismatching in Relation to Other Variables on the Outcomes of Myeloablative Unrelated Single Donor Umbilical Cord Blood Transplantation From 4/6 Matched Units in Children and Young Adults”, presented at the 2011, Honolulu, HI, 2011, vol. 17 No 2 Su, pp. S 185 - 186.
, “Docosahexaenoic Acid Does Not Improve Visual Function in Patients with Autosomal Recessive Stargardt Disease”, in Association for Research in Vision and Ophthalmology (ARVO), Ft. Lauderdale, FL, 2008.
, “D-Optimal Design for a Five-Parameter Logistic Model.”, in mODa 9–Advances in Model-Oriented Design and Analysis, Bertinoro, Italy, 2010, pp. 113-120.
, “Economic Evaluation of Treatment of Macular Edema Due to Central or Hemiretinal Vein Occlusion in the SCORE 2 Trial”, in Association for Research in Vision and Ophthalmology Annual Meeting, Virtual, 2021.
, “Economic Evaluation of Treatment of Macular Edema Due to Central or Hemiretinal Vein Occlusion in the SCORE 2 Trial”, in Association for Research in Vision and Ophthalmology Annual Meeting, Denver, Colorado, 2021.
, “The Effect of AREDS Supplementation on Visual Acuity Loss in Eyes with Advanced AMD”, in Meeting, Association for Research in Vision and Ophthalmology (ARVO), Fort Lauderdale, FL, 2005.
, “The Effect of Cataract Surgery on the Development of Geographic Atrophy”, in Annual Meeting, Association for Research in Vision and Ophthalmology (ARVO), Fort Lauderdale, FL, 2007.
, “The Effect of Riboxistaurin (RBX) on Visual Acuity Loss Due to Diabetic Macular Edema (DME)”, in 15th Scientific Meeting of the Eye Complications Study Group of the European Association for the Study of Diabetes (EASDec), Coimbra, Portugal, 2005.
, “The Effect of the Oral PKC b Inhibitor, Ruboxistaurin, on Visual Loss and Diabetic Macular Edema”, in 24th Annual American society of Retinal Specialists and the 6th Annual European Vitreoretinal Society Meeting, Cannes, France, 2006.
, “The Effect of the PKC b Inhibitor Ruboxistaurin on Moderate Visual Loss: The PKC-DRS2 Trial Baseline Characteristics and Preliminary Results”, in American Academy of Ophthalmology, Chicago, IL, 2005.
, “Effective Monitoring Strategies in a Long-term Clinical Trial with Varying Levels of Clinic Staff”, in Society for Clinical Trials, Miami, FL, 2012.
, “Effects of Breastfeeding in Women Taking Antiepileptic Drugs on Their Children’s Cognitive Outcomes”, in American Academy of Neurology Annual Meeting, Chicago, IL, 2008.
, “The Effects of Clinical Turnover on a Large Multi-Center Trial.”, in 31st Annual Meeting of the Society for Clinical Trials, Baltimore, MD, 2010.
, “Egg Oral Immunotherapy (OIT) Induces Clinical Desensitization in a Double-Blind, Placebo-Controlled (DBPC) Trial in Egg Allergic Children from the Consortium of Food Allergy Research (CoFAR).”, in Annual Meeting of the American Academy of Allergy, Asthma, and Immunology, New Orleans, 2010.
, “Electronic Data Acquisition”, in Society for Clinical Trials, St. Louis MO, 2008.
,